Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"The early results released from the Nice Insight survey highlight how much
work companies need to do to improve customer awareness and perception. This
type of marketing intelligence is not easily available, which is what makes
the Nice Insight product offering appealing as a tool to aid strategic
decision-making."
CLIFF BRIDGES GLOBAL MARKETING & HR COMMUNICATIONS DIRECTOR OF PGI  
Pharma Chem Outsourcing 2013
September 16-18 Long Branch, NJ |
Boehringer Ingelheim GmbH Catalent Pharma Solutions, Inc. Corealis Pharma, Inc. Dr. Reddy's Laboratories Ltd. Aptalis Pharmaceutical Technologies Galenix Inc. IriSys, Inc. Lupin Pharmaceuticals, Inc. Quay Pharmaceuticals Therapure Biopharma, Inc.
CIMA Labs Inc. delivers technologies to commercialize new drugs and extend the product life cycle of established brands. The company's drug delivery expertise includes R&D, formulation, manufacturing and packaging. Its range of drug delivery technologies suit various APIs and address product life cycle challenges and include: orally disintegrating tablets; taste-masking expertise; oral transmucosal; tamper-deterrent technology; oral granules and powder; customized release profiles; and solubilization technology.
http://
Regions
Stock Symbol Private Filter of 's services per Nice Insight Categories
Contact 
|
|
|
